MYONEX TO ACQUIRE CREAPHARM’S CLINICAL & COMMERCIAL PACKAGING AND BIOSERVICES BUSINESS
Horsham, PA, USA March 15, 2024 – Myonex, a leading global clinical trial supply company, has reached an agreement with the owners of Creapharm Group to acquire the Creapharm Clinical Packaging & Distribution and Commercial Packaging business and bioservices, headquartered in Reims, France with additional locations in Bordeaux and Bailly-Romainvilliers, France, and Marietta, Georgia, USA.
CREAPHARM BIOSERVICES obtient de l’ANSM l’autorisation d’ouverture d’établissements pharmaceutiques et étend ses activités aux médicaments de thérapie innovante
CREAPHARM BIOSERVICES obtained Manufacturer’s Authorisation from the ANSM
AUTHORIZED AS A PHARMACEUTICAL COMPANY BY FRENCH REGULATORY AUTHORITIES (ANSM), CREAPHARM BIOSERVICES EXPANDS ITS SCOPE TO INCLUDE ADVANCED THERAPY MEDICINAL PRODUCTS
On the occasion of its third aniversary, the biobank which integrated CREAPHARM GROUP as CREAPHARM BIOSERVICES, got its Manufacturer’s Authorisation from the French National Agency for Medicines and Health Products (ANSM*) on August 21th 2023.
Mise en synergie des expertises de Delpharm et Creapharm pour accompagner HMNC Brain Health
DELPHARM & CREAPHARM annoncent avoir uni leurs forces pour offrir le meilleur accompagnement à HMNC Brain Health
DELPHARM & CREAPHARM announced they have successfully joined forces to better serve HMNC Brain Health and met the FPI deadline in its BH-200-03 European phase 2 clinical trial.
DELPHARM and CREAPHARM announced today that they have combined their expertises to synergistically support HMNC Brain Health, a global clinical-stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry.
DELPHARM & CREAPHARM announced they have successfully joined forces to better serve HMNC Brain Health and met the FPI deadline in its BH-200-03 European phase 2 clinical trial
